Cat care interview veterinarian Dr Susan Little
We interviewed world-renowned feline healthcare specialist Dr Susan Little to get her thoughts on cat care. Click here to read and find out more.
Search
Empowering all employees
Boehringer Ingelheim has been awarded as a Global Top Employer for the second year in succession. Find out more about why we are a Global Top Employer.
World Water Day: Good Health Hinges on Good Water
Water availability and quality affects many aspects of individual, societal and environmental health. Good health hinges on good water. Learn more here.
COVID-19 Volunteering in the U.S.
BI employees across the U.S. are out in their communities making a difference to help improve the lives of those who have been impacted by the coronavirus.
Green Chemistry
Green Chemistry is critical for us as it balances the long-term sustainability of business, society, and the environment. Click here to learn more.
COVID-19 Boehringer Ingelheim Clinical Trials
We are doing everything we can to limit the impact COVID-19 could have on our clinical trial programs. Click here to find out and learn more.
Supporting local communities by offsetting carbon emissions
Boehringer Ingelheim supports carbon emissions reduction projects by partnering with ClimateSeed. Click here to find out more information about this.
Obesity osteoarthritis in pets a blind spot
Body weight is just one indicator among many when it comes to a pet’s health status, but there are some diseases associated with it. Learn more here.
COVID-19 In Colombia we support integrally
At Boehringer Ingelheim Colombia, we are caring for those in the most vulnerable situations during COVID-19. Click here to learn more about our work.
Biberach
Boehringer Ingelheim has a research and production network across the globe. Click here to read and find out information about our Biberach site.
Women in STEM 2022
Meet three of Boehringer Ingelheim's female scientists and learn why and how women are making a difference in STEM. Click here to find out more.
Circular economy towards the future
Boehringer Ingelheim uses eco-design to shape and develop animal health products with an improved environmental profile. Click here to read more.
Transboundary and emerging diseases
We fight TEDs through cutting-edge technologies. Click here to find out how our colleagues in Global Innovation and VPH prepare for outbreaks.
Our-position
12 years ago, several leading German companies including Boehringer Ingelheim came together to launch Afrika Kommt! Learn more about it here.
BI Access to Healthcare Strategy_Availability
Through our Access to Healthcare Strategy, we want to ensure that our compounds are readily and responsibly available. Learn more about our work here.
The METAmorphosis
At Boehringer Ingelheim’s META offices in the Middle East, Turkey and Africa all offices in the region are already free of single-use plastic. Learn more.
Duluth
Boehringer Ingelheim has a research and production network across the globe. Click here to read and find out information about our Duluth site.
Resizing our Carbon Footprint
The ecological balance of the world is at a tipping point. Thus, we step up the initiative “Carbon Footprint”. Click here to find out more information.
Sant Cugat del Vallès
Boehringer Ingelheim has a research and production network across the globe. Click here to read and find out information about our Shanghai site.
COVID-19 Q&A for people with chronic respiratory conditions
Here you can find a summary of COVID-19 advice for those with chronic respiratory conditions. Click here to read the questions and answers and learn more.
Stroke, Don’t Stay at Home
During COVID-19, there was a decrease in stroke hospital admissions. Learn why it is crucial that patients can still access urgent care at this time.
Quick response in fighting Foot-and-Mouth-Disease
Colleagues from the Veterinary Public Health helped to contain an outbreak of Foot-and-Mouth Disease (FMD) on the island of Rodrigues in just six days.
3 scopes for sustainability Saint Vulbas France
Click here to find out how Boehringer Ingelheim is working to improve the sustainability and biodiversity of the research site at Saint-Vulbas in France.
COVID-19 Ivermectin Animal Health Not for Human Use
BI manufactures several veterinary products containing ivermectin. They are not approved or suitable for use in humans to try to prevent or treat COVID-19.
Yamagata
Boehringer Ingelheim has a research and production network across the globe. Click here to read and find out information about our Yamagata site.